IL103298A0 - Anti-endotoxin compounds and related molecules and methods - Google Patents

Anti-endotoxin compounds and related molecules and methods

Info

Publication number
IL103298A0
IL103298A0 IL103298A IL10329892A IL103298A0 IL 103298 A0 IL103298 A0 IL 103298A0 IL 103298 A IL103298 A IL 103298A IL 10329892 A IL10329892 A IL 10329892A IL 103298 A0 IL103298 A0 IL 103298A0
Authority
IL
Israel
Prior art keywords
methods
related molecules
endotoxin
compounds
endotoxin compounds
Prior art date
Application number
IL103298A
Other languages
English (en)
Original Assignee
Eisai Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/935,050 external-priority patent/US5530113A/en
Application filed by Eisai Research Inst filed Critical Eisai Research Inst
Publication of IL103298A0 publication Critical patent/IL103298A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
IL103298A 1991-10-11 1992-09-27 Anti-endotoxin compounds and related molecules and methods IL103298A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77610091A 1991-10-11 1991-10-11
US07/935,050 US5530113A (en) 1991-10-11 1992-08-25 Anti-endotoxin compounds

Publications (1)

Publication Number Publication Date
IL103298A0 true IL103298A0 (en) 1993-02-21

Family

ID=27119147

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103298A IL103298A0 (en) 1991-10-11 1992-09-27 Anti-endotoxin compounds and related molecules and methods

Country Status (12)

Country Link
US (3) US5612476A (fi)
EP (1) EP0536969A3 (fi)
JP (1) JP3865411B2 (fi)
CN (1) CN1071668A (fi)
AU (1) AU660325B2 (fi)
CA (1) CA2079971A1 (fi)
FI (1) FI924579A (fi)
HU (1) HUT64538A (fi)
IL (1) IL103298A0 (fi)
NO (1) NO180491C (fi)
NZ (1) NZ244643A (fi)
RU (1) RU2095366C1 (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
US5530113A (en) * 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5648343A (en) * 1994-02-28 1997-07-15 The University Of Georgia Research Foundation Method for treating LPS-mediated disorders
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5750664A (en) 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
WO1997011708A1 (en) * 1995-09-29 1997-04-03 Eisai Research Institute Method for treating alcoholic liver disease
ATE298578T1 (de) * 1996-07-03 2005-07-15 Eisai Co Ltd Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung
WO1998055106A1 (en) * 1997-05-23 1998-12-10 Eisai Co., Ltd. Method for preparing pharmaceutical formulation
US6368604B1 (en) 1997-09-26 2002-04-09 University Of Maryland Biotechnology Institute Non-pyrogenic derivatives of lipid A
EP1111390A4 (en) 1998-09-01 2007-11-14 Eisai R&D Man Co Ltd METHOD FOR EVALUATING INJECTIONS CONTAINING LIPID A ANALOGS
WO2000042994A2 (en) * 1999-01-21 2000-07-27 North Shore-Long Island Jewish Research Institute Inhibition of bacterial dissemination
US20040006242A1 (en) 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
TR200102325T2 (tr) 1999-02-10 2002-08-21 Sankyo Company Limited Eter tipi lipid A 1-karbosiklik asit analogları
JP2003514824A (ja) 1999-11-15 2003-04-22 ビオミラ，インコーポレーテッド 合成脂質−ａ類似体およびその使用
US6861512B2 (en) 2000-03-01 2005-03-01 Eisai Co., Ltd. Separation of olefinic isomers
AU2001246858A1 (en) * 2000-04-06 2001-10-23 Sankyo Company Limited 1-carboxymethyl analogues of lipid a
CN1606446A (zh) * 2000-05-19 2005-04-13 科里克萨有限公司 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法
JP2004503472A (ja) * 2000-06-09 2004-02-05 エーザイ株式会社 ボーラスまたは間欠的な静脈内注入による、抗内毒素薬の投与
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
US20040198652A1 (en) * 2001-04-24 2004-10-07 Carter J. Paul Methods and compositions for preventing and treating septic shock and endotoxemia
WO2002088156A1 (fr) * 2001-04-26 2002-11-07 Sankyo Company, Limited Derivé d'acide 1-carboxylique de lipide a
AU2002323106A1 (en) 2001-08-10 2003-02-24 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
WO2004058788A1 (ja) * 2002-12-24 2004-07-15 Sankyo Company, Limited 右糖グルコースリピドa類縁体
US7906633B2 (en) * 2003-02-20 2011-03-15 Eisai R&D Management Co., Ltd. Reagents and methods for preparing LPS antagonist B1287 and stereoisomers thereof
US7951232B2 (en) * 2006-02-09 2011-05-31 Elevance Renewable Sciences, Inc. Surface coating compositions and methods
WO2007092633A2 (en) * 2006-02-09 2007-08-16 Elevance Renewable Sciences, Inc. Antimicrobial compositions, methods and systems
PT2068918E (pt) * 2006-09-26 2012-08-06 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US8518903B2 (en) 2007-04-19 2013-08-27 University of Pittsburgh—of the Commonwealth System of Higher Education Use of toll-like receptor-9 agonists
EP2437753B1 (en) 2009-06-05 2016-08-31 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
US9072760B2 (en) 2010-09-24 2015-07-07 University of Pittsburgh—of the Commonwealth System of Higher Education TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US10668092B2 (en) 2010-09-24 2020-06-02 The John Hopkins University Compositions and methods for treatment of inflammatory disorders
WO2012088425A2 (en) 2010-12-22 2012-06-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
CA2832307A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
BR112014028476A2 (pt) 2012-05-16 2017-08-01 Immune Design Corp fragmento imunogênico de um polipeptídeo, polinucleotídeo isolado, composição farmacêutica imunogênica, métodos para tratar uma infecção, para gerar uma resposta imune em um sujeito, e para imunizar um sujeito
US9562066B2 (en) 2012-09-25 2017-02-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Oral therapy of necrotizing enterocolitis
WO2014172637A1 (en) 2013-04-18 2014-10-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
RU2564918C1 (ru) * 2014-05-07 2015-10-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургская государственная медицинская академия" Министерства здравоохранения Российской Федерации /ГБОУ ВПО ОрГМА Минздрава России/ Средство для снижения системной патологической эндотоксинемии
EP3522893A4 (en) * 2016-10-04 2020-08-26 University Of Maryland, Baltimore METHODS OF TREATMENT OF SEPTICEMIA USING LIPID A-BASED THERAPEUTIC AGENTS (ASLA) ANTISEPSY
CN114315893B (zh) * 2021-12-22 2023-08-25 科之杰新材料集团有限公司 一种季铵盐功能单体及其制备方法、高适应性聚羧酸保坍剂及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495346A (en) * 1981-03-30 1985-01-22 Wisconsin Alumni Research Foundation Method of preparing a disaccharide
US5057598A (en) * 1983-05-06 1991-10-15 Centocor, Inc. Monoclonal antibodies reactive with endotoxin core
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
JPS6153295A (ja) * 1984-08-24 1986-03-17 Dai Ichi Seiyaku Co Ltd ジサツカライド誘導体
US5066794A (en) * 1984-08-24 1991-11-19 Daiichi Pharmaceutical Co., Ltd. Process for preparing a disaccharide derivative
NL8601551A (nl) * 1985-06-28 1987-01-16 Sandoz Ag Nieuwe saccharides, hun bereiding en farmaceutische samenstellingen, die hen bevatten.
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
JP2535048B2 (ja) * 1988-02-29 1996-09-18 第一製薬株式会社 新規ジサッカライド誘導体及びその塩
US5134230A (en) * 1988-03-02 1992-07-28 Daiichi Pharmaceutical Co., Ltd. 2-Deoxy-2-aminoglucopyranoside derivatives
ZA881430B (fi) * 1988-03-02 1988-10-28
JPH0219319A (ja) * 1988-05-26 1990-01-23 Duphar Internatl Res Bv ラクツロースシロップから単離したフラクション及びこれを有効成分とする抗内毒素作用を有する医薬組成物
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5158939A (en) * 1989-07-21 1992-10-27 Wisconsin Alumni Research Foundation Method of stimulating the immune systems of animals and compositions useful therefor
US5041427A (en) * 1989-07-21 1991-08-20 Wisconsin Alumni Research Foundation Lipid A derivatives
JPH0655749B2 (ja) * 1989-09-20 1994-07-27 日本たばこ産業株式会社 リピッドａ単糖類縁体
JP2839916B2 (ja) * 1989-10-20 1998-12-24 三共株式会社 リピドａ３位エーテル類縁体
US5158941A (en) * 1990-06-08 1992-10-27 E. I. Du Pont De Nemours And Company Lipid A analog as stimulant for production of interleukin-1 in human monocytes and tumor cell growth inhibitor
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
IL105131A (en) * 1992-03-27 2000-06-01 Igen Inc Compounds and compositions containing such compounds comprising lipid-A analogs for eliciting therapeutic antibodies

Also Published As

Publication number Publication date
NZ244643A (en) 1995-07-26
AU660325B2 (en) 1995-06-22
RU2095366C1 (ru) 1997-11-10
AU2526692A (en) 1993-04-22
US5843918A (en) 1998-12-01
NO923939D0 (no) 1992-10-09
US5612476A (en) 1997-03-18
NO180491C (no) 1997-04-30
HUT64538A (en) 1994-01-28
HU9203204D0 (en) 1992-12-28
CN1071668A (zh) 1993-05-05
NO923939L (no) 1993-04-13
JP3865411B2 (ja) 2007-01-10
NO180491B (no) 1997-01-20
FI924579A0 (fi) 1992-10-09
EP0536969A2 (en) 1993-04-14
US5756718A (en) 1998-05-26
EP0536969A3 (en) 1994-05-18
CA2079971A1 (en) 1993-04-12
JPH05194470A (ja) 1993-08-03
FI924579A (fi) 1993-04-12

Similar Documents

Publication Publication Date Title
IL103298A0 (en) Anti-endotoxin compounds and related molecules and methods
ZA927751B (en) Anti-endotoxin compound and related molecules and methods.
GB9105245D0 (en) Binding molecules
GB9111912D0 (en) Analytical methods
GB9422158D0 (en) N-acylindoles and related compounds
ZA947833B (en) 4-Arylamino-benzopyran and related compounds
EP0734398A4 (en) COMPOUNDS AND METHODS
GB9017083D0 (en) Therapeutically useful molecules
GB9310467D0 (en) Glycoconjugates
GB2244775B (en) Screws
GB9224897D0 (en) Analysis
GB9125579D0 (en) Binding molecules 1
GB9125582D0 (en) Binding molecules 2
GB2268878B (en) Duvet
GB9301919D0 (en) Synthetically-interlinked molecules
KR0110682Y1 (en) Leaf sprg
KR0110355Y1 (en) Siren
IL98019A0 (en) Screws
AU1014P (en) GM 61/1 Prunus dawyckensis
GB9318618D0 (en) Sequential ordering of molecules
GB9122127D0 (en) Door
AU114341S (en) Door
GB9118698D0 (en) Receptor molecules
GB9122130D0 (en) Analysis
AU120043S (en) Buffet - (3 door)